Related references
Note: Only part of the references are listed.Stress-Inducible Regulation of Heat Shock Factor 1 by the Deacetylase SIRT1
Sandy D. Westerheide et al.
SCIENCE (2009)
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models
Ghazaleh Sadri-Vakili et al.
HUMAN MOLECULAR GENETICS (2007)
Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models
Gabriele Schilling et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration
Patrick Weydt et al.
CELL METABOLISM (2006)
Depletion of CBP is directly caused by mutant huntingtin
Haibing Jiang et al.
NEUROBIOLOGY OF DISEASE (2006)
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
G Gardian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neuronal intranuclear inclusions and neuropil aggregates in Hdh(CAG(150)) knockin mice
SJ Tallaksen-Greene et al.
NEUROSCIENCE (2005)
Huntingtin-protein interactions and the pathogenesis of Huntington's disease|
SH Li et al.
TRENDS IN GENETICS (2004)
CRE-mediated transcription is increased in Huntington's disease transgenic mice
K Obrietan et al.
JOURNAL OF NEUROSCIENCE (2004)
Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease
RJ Ferrante et al.
JOURNAL OF NEUROSCIENCE (2004)
Ca2+/CREB/CBP-dependent gene regulation:: a shared mechanism critical in long-term synaptic plasticity and neuronal survival
H Bito et al.
CELL CALCIUM (2003)
The hunt for huntingtin function: interaction partners tell many different stories
P Harjes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein
JP Taylor et al.
GENES & DEVELOPMENT (2003)
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
E Hockly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice
ZX Yu et al.
HUMAN MOLECULAR GENETICS (2002)
Environmental enrichment slows disease progression in R61/2 Huntington's disease mice
E Hockly et al.
ANNALS OF NEUROLOGY (2002)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA
G Schilling et al.
NEUROBIOLOGY OF DISEASE (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
JS Steffan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
CREB-binding protein sequestration by expanded polyglutamine
A McCampbell et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
